41. KrasG12D mutation contributes to regulatory T cell conversion through activation of the MEK/ERK pathway in pancreatic cancer. (1st April 2019) Authors: Cheng, He; Fan, Kun; Luo, Guopei; Fan, Zhiyao; Yang, Chao; Huang, Qiuyi; Jin, Kaizhou; Xu, Jin; Yu, Xianjun; Liu, Chen Journal: Cancer letters Issue: Volume 446(2019) Page Start: 103 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
42. Lipid raft involvement in signal transduction in cancer cell survival, cell death and metastasis. Issue 1 (22nd December 2021) Authors: Li, Borui; Qin, Yi; Yu, Xianjun; Xu, Xiaowu; Yu, Wenyan Journal: Cell proliferation Issue: Volume 55:Issue 1(2022) Page Start: n/a Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
43. Management of Small Nonfunctioning Pancreatic Neuroendocrine Tumors: An Analysis of the US Surveillance, Epidemiology, and End Results Database. Issue 1 (January 2021) Authors: Ji, Shunrong; Liu, Mengqi; Xia, Huanyu; Ye, Zeng; Xu, Xiaowu; Yu, Xianjun; Zhuo, Qifeng Journal: Pancreas Issue: Volume 50:Issue 1(2021) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
44. Metabolic tumor burden is associated with major oncogenomic alterations and serum tumor markers in patients with resected pancreatic cancer. Issue 2 (1st May 2015) Authors: Shi, Si; Ji, Shunrong; Qin, Yi; Xu, Jin; Zhang, Bo; Xu, Wenyan; Liu, Jiang; Long, Jiang; Liu, Chen; Liu, Liang; Ni, Quanxing; Yu, Xianjun Journal: Cancer letters Issue: Volume 360:Issue 2(2015) Page Start: 227 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
45. Metabolic tumor burden: A new promising way to reach precise personalized therapy in PDAC. Issue 2 (10th April 2015) Authors: Xiang, Jinfeng; Liu, Liang; Wang, Wenquan; Xu, Huaxiang; Wu, Chuntao; Xu, Jin; Liu, Chen; Long, Jiang; Ni, Quanxing; Yu, Xianjun Journal: Cancer letters Issue: Volume 359:Issue 2(2015) Page Start: 165 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
46. Metabolic tumor burden: A new promising way to reach precise personalized therapy in PDAC. Issue 2 (10th April 2015) Authors: Xiang, Jinfeng; Liu, Liang; Wang, Wenquan; Xu, Huaxiang; Wu, Chuntao; Xu, Jin; Liu, Chen; Long, Jiang; Ni, Quanxing; Yu, Xianjun Journal: Cancer letters Issue: Volume 359:Issue 2(2015) Page Start: 165 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
47. MiR‐29a, targeting caveolin 2 expression, is responsible for limitation of pancreatic cancer metastasis in patients with normal level of serum CA125. Issue 11 (29th September 2018) Authors: Liang, Chen; Shi, Si; Meng, Qingcai; Liang, Dingkong; Hua, Jie; Qin, Yi; Zhang, Bo; Xu, Jin; Ni, Quanxing; Yu, Xianjun Journal: International journal of cancer Issue: Volume 143:Issue 11(2018) Page Start: 2919 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
48. Molecular Mechanism Underlying Lymphatic Metastasis in Pancreatic Cancer. (22nd January 2014) Authors: Xiao, Zhiwen; Luo, Guopei; Liu, Chen; Wu, Chuntao; Liu, Liang; Liu, Zuqiang; Ni, Quanxing; Long, Jiang; Yu, Xianjun Other Names: Takao Sonshin Academic Editor. Journal: BioMed research international Issue: Volume 2014(2014) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
49. MUC16 C terminal-induced secretion of tumor-derived IL-6 contributes to tumor-associated Treg enrichment in pancreatic cancer. (1st April 2018) Authors: Fan, Kun; Yang, Chao; Fan, Zhiyao; Huang, Qiuyi; Zhang, Yiyin; Cheng, He; Jin, Kaizhou; Lu, Yu; Wang, Zhengshi; Luo, Guopei; Yu, Xianjun; Liu, Chen Journal: Cancer letters Issue: Volume 418(2018) Page Start: 167 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
50. Novel recurrence risk stratification of resected pancreatic neuroendocrine tumor. (1st January 2018) Authors: Gao, Heli; Liu, Liang; Wang, Wenquan; Xu, Huaxiang; Jin, Kaizhou; Wu, Chuntao; Qi, Zihao; Zhang, Shirong; Liu, Chen; Xu, Jinzhi; Ni, Quanxing; Yu, Xianjun Journal: Cancer letters Issue: Volume 412(2018) Page Start: 188 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗